Position in ARGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$411,920,598
-$22,356,884 QoQ
Shares Held
443,990
-25.3% QoQ
Ownership
0.714%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#11
of 504 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,221,834,024 across 296 Biotechnology names. ARGX ranks #5 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
This page
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in ARGX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $411,920,598 | 443,990 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $434,277,482 | 594,697 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $350,178,304 | 416,408 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $62,632,855 | 84,919 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $134,357,666 | 243,746 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $226,530,999 | 382,741 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $248,469,840 | 404,016 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $235,000,350 | 433,516 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $86,641,016 | 201,472 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $165,029,704 | 419,155 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $165,956,117 | 436,233 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $211,787,810 | 430,787 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $35,194,566 | 90,305 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $21,337,282 | 57,269 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $27,589,051 | 72,827 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $16,939,338 | 47,980 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $12,834,180 | 33,874 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $10,627,838 | 33,706 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $17,534,012 | 50,070 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $14,657,570 | 48,535 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $14,408,005 | 47,856 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $76,061,340 | 276,195 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $71,858,244 | 244,341 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $79,831,544 | 304,097 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $82,042,730 | 364,262 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||